Preclinical Data at AACR Show CSP May Be Broad Target in Cholangiocarcinoma
April 13th 2022Researchers presented results for ZB131, a monoclonal antibody that would target cancer-specific plectin (CSP); experiments with mice showed this may be present in more than 80% of the most common types of cholangiocarcinoma.
Read More
Dr Roxana Siles: Multispecialty Management of Chronic Cough Maximizes Patient Benefits
April 12th 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the factors that contribute to necessitating multispecialty management of patients with chronic cough.
Watch
Pretreatment PROs May Have Survival Implications in DLBCL, Finds Exploratory Study
April 12th 2022The researchers found that the prognostic values for both overall and progression-free survival remained even after adjusting for the International Prognostic Index, a widely used prognostic model of outcomes for the disease.
Read More
AstraZeneca’s Camille Hertzka Addresses rPFS in mCRPC
April 12th 2022Camille Hertzka, vice president, head of oncology, US Medical, AstraZeneca, clarifies testing for the HRR mutation in metastatic castrate-resistant prostate cancer (mCRPC) and the predictive importance of radiographic progression-free survival (rPFS) for overall survival in this setting.
Watch
Study Finds No Association Between Targeted DMARDs, ADRD Risk Among Patients With RA
April 12th 2022Researchers found no association between the use of tofacitinib, tocilizumab, or tumor necrosis factor (TNF) inhibitors and risk of developing Alzheimer disease and related dementia (ADRD) among older patients with rheumatoid arthritis (RA).
Read More
Dr Marc-Andre Cornier on the Importance of Behavioral Interventions for Weight Loss
April 11th 2022Marc-Andre Cornier, MD, professor and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina, outlines the necessary components for a successful weight loss program.
Watch
New Minimal Residual Disease Assessment Could Detect Disease Progression Earlier in MM
April 11th 2022Flow–minimal residual disease (MRD) assessment in patients with multiple myeloma (MM) was found to be a good tool for early detection of MRD and could aid providers in treatment decision-making.
Read More
LMOD3 Gene Variant Identified in Hypersomnolence Case With Potential Kleine-Levin Syndrome
April 10th 2022Kleine-Levin syndrome is rare and difficult to diagnose, especially when symptoms are atypical. Recent research points to LMOD3 variations as a potential diagnostic marker if confirmed by further research.
Read More
Examining Changes in STEMI Treatment Strategies and Outcomes in CKD Over Time
April 9th 2022Despite underrepresentation in clinical trials of acute coronary syndrome treatments, a recent study suggests treatment strategies and outcomes in chronic kidney disease patients with ST-elevation myocardial infarctions (STEMI) have improved over time.
Read More
Mixed QOL Findings Following Treatment Highlight Need for BC Support Services
April 9th 2022This subanalysis of data from the ECOG-ACRIN E5103 trial evaluated longer-term quality of life (QOL) at the 18-month mark among patients with lymph node–positive or high-risk lymph node–negative breast cancer (BC) who have completed active treatment.
Read More
Biomarker Identifies CRSwNP Endotypes, Risk of Postoperative Nasal Polyp Recurrence
April 9th 2022Circulating B cell–activating factor was shown to be a potential biomarker in identifying blood eosinophil counts and risk of postoperative nasal polyp recurrence among patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Read More